NASDAQ$JYNT
The Joint Corp · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
The Joint Corp. grew revenue and improved bottom-line year-over-year.
The Joint Corp. reported a 5% increase in revenue to $29.7 million and operating income of $1.1 million. Net income was $947,000, compared to $2.3 million in the previous year, which included a $3.9 million employee retention credit. System-wide sales increased by 9% to $126.3 million, and system-wide comp sales grew by 3%.
- Revenue grew by 5% to $29.7 million.
- Operating income was $1.1 million, compared to an operating loss of $653,000.
- Net income was $947,000, compared to $2.3 million, which included a $3.9 million employee retention credit in the prior year.
- System-wide sales increased by 9% to $126.3 million.
Headline financials
Revenue & EPS history
The Joint · Revenue · Quarterly
$29.7M
Forward guidance
The company reiterated all elements of its guidance.
Tailwinds
- 2024 System-wide sales are expected to be between $530 and $545 million dollars, compared to $488.0 million dollars in 2023.
- System-wide comp sales for all clinics open 13 months or more are expected to be in the mid-single digits in 2024.
- 2024 new franchised clinic openings, excluding the impact of refranchised clinics, are expected to be between 60 and 75, compared to 104 in 2023.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
+1.5%
Avg return
Earnings day
+3.3%
Avg return
5 days after
+3.8%
Avg return
30 days after
53%
25 / 47 earnings
Positive
+26.0%
Q1 2024
Best reaction
-42.3%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.5% | -2.2% | -6.0% | |
| Q4 2025 | +2.0% | +1.9% | +6.3% | |
| Q3 2025 | -3.9% | +4.6% | +6.1% | |
| Q1 2025 | -5.0% | -5.2% | +14.1% | |
| Q4 2024 | +4.6% | +17.9% | -1.3% | |
| Q3 2024 | -2.8% | -1.7% | -3.1% | |
| Q2 2024 | -5.1% | -3.6% | -8.7% | |
| Q1 2024 | +26.0% | +26.1% | +17.4% | |
| Q4 2023 | +25.7% | +29.8% | +34.8% | |
| Q3 2023 | +1.3% | +4.6% | +15.1% | |
| Q2 2023 | +1.8% | -0.2% | -14.6% | |
| Q1 2023 | -3.1% | -2.2% | -11.2% | |
| Q4 2022 | +2.3% | +1.4% | -1.2% | |
| Q3 2022 | -4.6% | -3.3% | +1.6% | |
| Q2 2022 | +15.2% | +7.8% | -9.6% | |
| Q1 2022 | -42.3% | -43.6% | -46.2% | |
| Q4 2021 | -9.9% | -20.8% | -24.7% | |
| Q3 2021 | +5.8% | +8.6% | -21.8% | |
| Q2 2021 | +18.9% | +17.8% | +22.0% | |
| Q1 2021 | -4.5% | -6.8% | +28.2% | |
| Q4 2020 | -10.0% | -14.9% | -7.0% | |
| Q3 2020 | +7.1% | +28.5% | +35.2% | |
| Q2 2020 | +13.5% | +15.1% | +23.7% | |
| Q1 2020 | +9.9% | +8.8% | +35.6% | |
| Q4 2019 | -3.0% | -10.8% | -42.2% | |
| Q3 2019 | -3.6% | -10.3% | -13.1% | |
| Q2 2019 | -0.1% | +0.0% | -6.2% | |
| Q1 2019 | +8.7% | +4.4% | -7.2% | |
| Q4 2018 | +12.6% | +21.5% | +42.4% | |
| Q3 2018 | +3.8% | +5.5% | +0.5% | |
| Q2 2018 | +8.5% | +3.9% | +2.8% | |
| Q1 2018 | -3.0% | +1.8% | +1.9% | |
| Q4 2017 | +8.2% | +23.7% | +35.9% | |
| Q3 2017 | +16.2% | +23.0% | +8.6% | |
| Q2 2017 | +3.6% | +2.7% | +34.5% | |
| Q1 2017 | +7.3% | +2.6% | -1.3% | |
| Q4 2016 | -15.3% | -11.4% | -15.8% | |
| Q3 2016 | +3.7% | +6.1% | -6.5% | |
| Q2 2016 | -0.5% | -0.9% | +28.9% | |
| Q1 2016 | -0.0% | — | — | |
| Q4 2015 | -21.5% | — | — | |
| Q3 2015 | -6.1% | — | — | |
| Q2 2015 | +1.3% | — | — | |
| Q1 2015 | +6.2% | — | — | |
| Q4 2014 | +4.0% | — | — | |
| Q3 2014 | -1.6% | — | — | |
| Q3 2013 | -1.6% | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro